Harvey Capital Management’s Labcorp LH Stock Holding History

Harvey Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,984	Closed	-$996K	–	82
2020 Q2	$996K	Buy	+6,984	New	+$966K	0.49%	43

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harvey Capital Management's LH Position: Q3 2020 in Review

Harvey Capital Management sold out of Labcorp (LH) in Q3 2020, closing a stake of 6,984 shares — an estimated $996K sold.

Harvey Capital Management first reported a position in LH in Q2 2020 and held it in 1 quarter. The position peaked at $996K in Q2 2020. 809 funds tracked by Wall St. Rank hold LH as of Q3 2020.

Harvey Capital Management reported no remaining Labcorp position as of Q3 2020 after selling out during the quarter.
Harvey Capital Management sold 6,984 Labcorp shares in Q3 2020, an estimated $996K.
Harvey Capital Management first reported a position in Labcorp in Q2 2020 and held it in 1 quarter.
Harvey Capital Management's Labcorp position peaked at $996K in Q2 2020.
809 funds tracked by Wall St. Rank held Labcorp as of Q3 2020.

Based on Harvey Capital Management's 13F filing for Q3 2020, filed 27 Oct 2020.